Catalyst Event
Gilead Sciences Inc (GILD) · Other
From KEDI U.S. Tech100 90% Participation + Daily Options Premium Index (KUSTC100P)
5/22/2026, 12:00:00 AM
Received a positive opinion from the CHMP on 2026-05-22 for Trodelvy for certain patients with first-line metastatic triple-negative breast cancer. Analysts forecast a medium price impact (>=5%) as a key step for European market expansion, expected.
Korean Translation
2026-05-22 유럽 의약품청(EMA) 산하 약물사용자문위원회(CHMP)로부터 특정 1차 전이성 삼중음성 유방암 환자를 위한 트로델비에 대한 긍정적 의견을 획득함. 분석가들은 유럽 시장 확대의 주요 단계로 5% 이상의 주가 영향이 있을 것으로 예상됨.
Related Recent Events
Datadog Inc (DDOG) · Earnings Release
Datadog Q2 2026 earnings release on August 6, 2026, scheduled. Market reaction is estimated to be significant (Medium) as earnings are primary price drivers for high-growth SaaS, scheduled
8/6/2026, 12:00:00 AM
Rocket Lab Corp (RKLB) · Earnings Release
Rocket Lab's Q2 2026 earnings release on 2026-08-06 expected.
8/6/2026, 12:00:00 AM
AppLovin Corporation (APP) · Earnings Release
AppLovin's Q2 2026 earnings release, which typically has low immediate price impact upon date announcement, is scheduled.
8/5/2026, 12:00:00 AM
Amgen Inc (AMGN) · Earnings Release
Amgen's Q2 2026 earnings release is scheduled for 2026-07-30. Price impact is estimated at Medium (>=5%) as historical earnings reports typically drive significant volatility. Analysts forecast EPS of approximately $5.59 on revenues of $9.42 billion forecasted.
7/30/2026, 12:00:00 AM
Monolithic Power Systems Inc (MPWR) · Earnings Release
Monolithic Power Systems' Q2 2026 earnings release is scheduled for 2026-07-30, with company revenue of $890 million to $910 million forecasted; importance is Low as market reaction is pending.
7/30/2026, 12:00:00 AM
Meta Platforms Inc (META) · Earnings Release
Meta's Q2 2026 earnings release is expected. Low price impact is estimated for the date announcement, though the actual results will likely be a high-impact event.
7/29/2026, 12:00:00 AM